CAF vs JOF

The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. While the stock appears undervalued with a P/E of 4.44 and a growth-based intrinsic value of $29.05, these metrics are overshadowed by a bearish technical trend (10/100) and poor fundamental health. The disconnect between recent price gains and the underlying deterministic scores suggests a speculative rally rather than a fundamental recovery. Overall, the extreme weakness in the health scorecard outweighs the apparent value proposition.

JOF presents a compelling deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a current price ($10.99) trading at a significant discount to both its Graham Number ($22.65) and Intrinsic Value ($16.87). The fund exhibits an exceptionally low P/E ratio of 4.56 compared to the sector average of 35.45, paired with a highly sustainable 9.69% dividend yield. While technical trends are currently bearish (0/100), the strong long-term price performance and robust revenue growth of 42.3% suggest a strong fundamental floor.